Julie Gerardi is the VP of Global Sales at Codex DNA. Julie joined Codex in 2019 and is responsible for sales and business development strategy worldwide. She brings 25 years of expertise in developing go-to-market strategy for laboratory automation and a keen understanding of biological drug discovery workflows to the commercial leadership team.
Julie joined Codex DNA from Definiens (AstraZeneca), where she held the position of Senior Director of Business Development in Strategic Markets, operationally in the Immuno-oncology arena. Prior to that she was the Drug Discovery Manager for Molecular Devices (Danaher). She has also been part of several successful start-ups including, Velocity11 which is now part of Agilent, and MWG Biotech, now a part of Eurofins.
Julie holds a B.S. Biotechnology Management/Biochemistry from Menlo College.